The Journal of Immunology, Vol 126, Issue 4 1415-1420, Copyright © 1981 by American Association of Immunologists

ARTICLES

Plasminogen activator is an apparent lymphocyte mitogen

SD Cohen, E Israel, B Spiess-Meier and MA Wainberg

Culture fluids of avian sarcoma virus (ASV)-transformed but not normal chicken embryo cells frequently elicited a mitogenic response in normal avian and murine lymphocytes. We examined the possibility that plasminogen activator (PA) might be responsible for the observed mitogenic effect. PA activity, present in culture medium, was correlated positively with lymphocyte mitogenic capacity. Treatment of cells with phorbol myristate acetate, which elevates PA levels, increased mitogenesis. Similar treatment with dexamethasone, which inhibits PA biosynthesis and/or secretion, reduced lymphocyte mitogenic activity. Addition to culture fluids of either benzamidine or diisopropylfluorophosphate, both specific PA inhibitors, blocked lymphocyte proliferative responsiveness to culture fluids. In contrast, neither epsilon-amino-caproic acid nor trasylol, which inhibits plasmin esterase activity but not PA, abrogated lymphocyte responsiveness. Furthermore, purified urokinase, an enzyme of similar substrate specificity to PA, had lymphocyte stimulatory activity. These results strongly suggest that PA can function as a lymphocyte mitogen.

This article has been cited by other articles:

				E. Abraham, M. R. Gyetko, K. Kuhn, J. Arcaroli, D. Strassheim, J. S. Park, S. Shetty, and S. Idell Urokinase-Type Plasminogen Activator Potentiates Lipopolysaccharide-Induced Neutrophil Activation J. Immunol., June 1, 2003; 170(11): 5644 - 5651. [Abstract] [Full Text] [PDF]

				M. R. Gyetko, S. Sud, G.-H. Chen, J. A. Fuller, S. W. Chensue, and G. B. Toews Urokinase-Type Plasminogen Activator Is Required for the Generation of a Type 1 Immune Response to Pulmonary Cryptococcus neoformans Infection J. Immunol., January 15, 2002; 168(2): 801 - 809. [Abstract] [Full Text] [PDF]